Inhibition of JAK1 in human adipocytes ameliorates IFNγ-mediated insulin resistance

被引：0
|
作者：
McGillicuddy, Fiona C. [1 ]
Chiquoine, Elise H. [1 ]
Hinkle, Christine C. [1 ]
Reilly, Muredach P. [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2008年 / 28卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
20
引用
收藏
页码：E35 / E35
页数：1
相关论文
共 50 条
  • [1] Treatment with a JAK1/2 inhibitor ameliorates murine autoimmune cholangitis induced by IFN overexpression
    Tihong Shao
    Patrick S. C. Leung
    Weici Zhang
    Koichi Tsuneyama
    William M. Ridgway
    Howard A. Young
    Zongwen Shuai
    Aftab A. Ansari
    M. Eric Gershwin
    Cellular & Molecular Immunology, 2022, 19 : 1130 - 1140
  • [2] Treatment with a JAK1/2 inhibitor ameliorates murine autoimmune cholangitis induced by IFN overexpression
    Shao, Tihong
    Leung, Patrick S. C.
    Zhang, Weici
    Tsuneyama, Koichi
    Ridgway, William M.
    Young, Howard A.
    Shuai, Zongwen
    Ansari, Aftab A.
    Gershwin, M. Eric
    CELLULAR & MOLECULAR IMMUNOLOGY, 2022, 19 (10) : 1130 - 1140
  • [3] Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC
    Kim, Dong Min
    Kim, Mi Jin
    Moon, Jai-Hee
    Lee, Eun Young
    Hong, Jun Ki
    Lee, Seul
    Koh, Dong-In
    Ryu, Yae Seong
    Kim, Seung Mi
    Jung, Soo-A
    Shin, Jae-Sik
    Kim, Joseph
    Park, Yoon Sun
    Hong, Seung-Woo
    Lee, So Hee
    Jung, Joonyee
    Park, Sang Soo
    Kim, Do Yeon
    Kim, Eun Ho
    Jeong, Hong-Rae
    Gong, Ji Hee
    Kim, Jieun
    Kim, Seung Chan
    Yu, Ha Na
    Ki, So Young
    Kim, Tae Won
    Jin, Dong-Hoon
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 527 (01) : 305 - 310
  • [4] Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
    Shin, Daniel Sanghoon
    Zaretsky, Jesse M.
    Escuin-Ordinas, Helena
    Garcia-Diaz, Angel
    Hu-Lieskovan, Siwen
    Kalbasi, Anusha
    Grasso, Catherine S.
    Hugo, Willy
    Sandoval, Salemiz
    Torrejon, Davis Y.
    Palaskas, Nicolaos
    Abril-Rodriguez, Gabriel
    Parisi, Giulia
    Azhdam, Ariel
    Chmielowski, Bartosz
    Cherry, Grace
    Seja, Elizabeth
    Berent-Maoz, Beata
    Shintaku, I. Peter
    Le, Dung T.
    Pardoll, Drew M.
    Diaz, Luis A., Jr.
    Tumeh, Paul C.
    Graeber, Thomas G.
    Lo, Roger S.
    Comin-Anduix, Begona
    Ribas, Antoni
    CANCER DISCOVERY, 2017, 7 (02) : 188 - 201
  • [5] JAK1/2 INHIBITION IN THE TREATMENT OF CGVHD
    Alchalby, H.
    Stuebig, T.
    Ayuk, F.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S539 - S540
  • [6] JAK1 inhibition and inflammatory bowel disease
    Harris, Clare
    Cummings, J. R. Fraser
    RHEUMATOLOGY, 2021, 60 : II45 - II51
  • [7] JAK1 inhibition and inflammatory bowel disease
    Harris, Clare
    Cummings, J. R. Fraser
    RHEUMATOLOGY, 2021, 60 (SUPPL 2) : ii45 - ii51
  • [8] Inhibition of JAK1 sensitizes human head and neck cancer cells to cetuximab
    Bonner, J. A.
    Trummell, H.
    Yang, E.
    ANNALS OF ONCOLOGY, 2019, 30
  • [9] IFNγ-induced PD-L1 expression is JAK2 but not JAK1 dependent and its inhibition enhances NK-cetuximab mediated ADCC of HNSCC cells
    Concha-Benavente, F.
    Ferris, R. L.
    ORAL ONCOLOGY, 2015, 51 (05) : E33 - E33
  • [10] JAK1 Inhibition to Treat Crohn's Disease
    Abreu, Maria T. T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 388 (21): : 2005 - 2009
12345